BioCentury
ARTICLE | Company News

CellMax Life sales and marketing update

December 1, 2016 8:06 PM UTC

CellMax launched its CellMax-DNA Genetic Cancer Risk Test in the U.S. The saliva-based test uses the company's SMSEQ platform to detect mutations in 98 genes across 24 hereditary cancers....

Get Unlimited Access
Continue reading with a free trial.
Or Purchase This Article

BCIQ Company Profiles

CellMax Life Inc.